Journal: bioRxiv
Article Title: ER stress-associated IRE1α signalling links impaired QPRT-dependent NAD⁺ biosynthesis to reduced oocyte competence
doi: 10.64898/2026.11.04.764453
Figure Lengend Snippet: (A) Schematic of the workflow for comparative proteomic analysis of denuded excellent-grade and poor-grade goat oocytes, including protein extraction, LC–MS/MS analysis, and downstream protein profiling. (B) Venn diagram showing the overlap between proteins identified in excellent-grade and poor-grade oocytes. (C) Principal component analysis (PCA) showing separation of the proteomic profiles of excellent-grade and poor-grade oocytes. (D) Partial least squares discriminant analysis (PLS-DA) score plot illustrating differences in protein profiles between the two groups. (E) Heatmap showing the relative abundance of differentially abundant proteins in excellent-grade and poor-grade oocytes. (F,G) Gene Ontology (GO) enrichment analysis of differentially abundant proteins associated with cellular components (F) and biological processes (G). Blue bars indicate proteins upregulated in poor-grade oocytes, whereas red bars indicate proteins downregulated in poor-grade oocytes. (H) Volcano plot showing differential protein abundance between excellent-grade and poor-grade oocytes, highlighting significantly altered proteins, including IRE1α. (I–K) RT-qPCR analysis of ER stress-associated transcripts in excellent-grade and poor-grade oocytes: (I) the ratio of spliced to unspliced XBP1 mRNA (XBP1s/XBP1u), (J) relative ATF6 mRNA expression, and (K) relative IRE1α (ERN1) mRNA expression. Each group comprised 250 oocytes. (L) Schematic of the experimental design used to assess meiotic maturation following treatment with tunicamycin ™ in excellent-grade oocytes, or tauroursodeoxycholic acid (TUDCA) and the IRE1α inhibitor STF-083010 (STF) in poor-grade oocytes, during in vitro maturation (IVM). (M–O) Quantification of the proportion of oocytes reaching metaphase II (MII) following pharmacological manipulation of ER stress signaling: (M) excellent-grade oocytes treated with or without TM; (N) poor-grade oocytes treated with or without STF; and (O) poor-grade oocytes treated with or without TUDCA. The numbers of oocytes analyzed are indicated above the bars. (P) Predicted secondary structure of QPRT mRNA showing a candidate stem– loop region containing a CUG motif. This computational prediction identifies a potential RNA structural feature for further investigation. (Q) Relative QPRT mRNA expression in excellent-grade oocytes and excellent-grade oocytes treated with TM, assessed by RT-qPCR. ® Relative QPRT mRNA expression in poor-grade oocytes following TUDCA treatment. (S) Relative IRE1α ( ERN1 ) mRNA expression in poor-grade oocytes following TUDCA treatment. (T) Schematic of the in vitro transcription and preparation of QPRT RNA substrates for the IRE1α-mediated RNA cleavage assay. (U) Representative RNA cleavage assay showing QPRT RNA incubated under the indicated conditions, including recombinant IRE1α. The accompanying table lists the sizes of the detected RNA products. (V) Schematic of the experimental workflow for assessing QPRT mRNA stability in excellent-grade and poor-grade oocytes following actinomycin D treatment to inhibit new transcription. (W) Relative QPRT mRNA abundance in excellent-grade and poor-grade oocytes at 0 and 3 h following actinomycin D treatment, assessed by RT-qPCR. Values are expressed relative to the corresponding 0-hr level. The number of oocytes analyzed is indicated above each graph. Data are presented as mean ± SEM. Statistical significance is indicated by asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Statistical significance was assessed using unpaired t-test and ordinary one-way ANOVA (N and O) and 2way ANOVA (W).
Article Snippet: STF-083010 ( MedChemExpress, HY-15845) was used to inhibit IRE1α activity.
Techniques: Analysis, Protein Extraction, Liquid Chromatography with Mass Spectroscopy, Profiling, Quantitative Proteomics, Quantitative RT-PCR, Expressing, In Vitro, In Vitro Transcription, Cleavage Assay, Incubation, Recombinant, Stability, Significance Assay